Cargando…

Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide and is strongly associated with metabolic deregulation. More recently, a significant impact of parental NAFLD in the offspring was demonstrated and has been widely discussed. However, pathogenetic pathways i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wajsbrot, Natalia Balassiano, Leite, Nathalie Carvalho, Salles, Gil F, Villela-Nogueira, Cristiane A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280730/ https://www.ncbi.nlm.nih.gov/pubmed/35978876 http://dx.doi.org/10.3748/wjg.v28.i25.2890

Ejemplares similares

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study
por: Cardoso, Claudia R. L., et al.
Publicado: (2021)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
por: Kalogirou, Maria Styliani, et al.
Publicado: (2022)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
por: Yousef, Mohamad H, et al.
Publicado: (2017)

Racial differences in prevalence and severity of non-alcoholic fatty liver disease
por: Bonacini, Maurizio, et al.
Publicado: (2021)

Therapies for non-alcoholic fatty liver disease: A 2022 update
por: Shen, Katie, et al.
Publicado: (2022)

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
por: Mato, José M, et al.
Publicado: (2019)

Relationship between non-alcoholic fatty liver disease and coronary heart disease
por: Arslan, Ugur, et al.
Publicado: (2020)

Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome
por: Sheng, Wei, et al.
Publicado: (2022)

Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver
por: Wang, Dan, et al.
Publicado: (2023)

Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
por: Chen, Hui-Ting, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
por: Mattos, Ângelo Z, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
por: Dietrich, Christoph G, et al.
Publicado: (2023)

Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship?
por: Janota, Barbara, et al.
Publicado: (2023)

Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
por: Ocker, Matthias
Publicado: (2020)

Anthropometric indicators of visceral adiposity as predictors of non-alcoholic fatty liver disease: A review
por: Almeida, Naiade Silveira, et al.
Publicado: (2018)

Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
por: Sofogianni, Areti, et al.
Publicado: (2020)

A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease
por: Skat‐Rørdam, Josephine, et al.
Publicado: (2019)

Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article
por: Chao, Che-Yung, et al.
Publicado: (2016)

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
por: Leoni, Simona, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics
por: Trovato, Guglielmo M
Publicado: (2020)

Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
por: Anirvan, Prajna, et al.
Publicado: (2021)

Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals
por: Bilic-Curcic, Ines, et al.
Publicado: (2021)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

Environmentally Induced Epigenetic Transgenerational Inheritance of Reproductive Disease(1)
por: Nilsson, Eric E., et al.
Publicado: (2015)

Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
por: Baratta, Francesco, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?
por: Mandour, Mandour Omer, et al.
Publicado: (2022)

NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?
por: Villela-Nogueira, Cristiane A., et al.
Publicado: (2016)

Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach
por: Perez-Carreras, Mercedes, et al.
Publicado: (2021)

Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
por: Jeyakumar, Shanmugam Murugaiha, et al.
Publicado: (2022)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Fatty liver and celiac disease: Why worry?
por: Narciso-Schiavon, Janaina Luz, et al.
Publicado: (2023)

Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
por: Tidwell, Jasmine, et al.
Publicado: (2023)

Celiac disease: From genetics to epigenetics
por: Gnodi, Elisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qldoce2hcsjm44r9joog52n8s9